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Purpose/Objective: Adaptive radiotherapy aims to adjust the 
treatment plan during the treatment course to ensure correct 
target coverage and to avoid normal tissue complications. 
The goal of this study was to investigate the effectiveness of 
an adaptive planning procedure incorporating offline dose 
feed-back to manage the entire treatment planning. To this 
purpose a retrospective analysis was performed on fifteen 
patients with prostatic tumor treated with IGRT-IMRT.  
Materials and Methods: A Siemens ArtisteTM was used for 
IGRT-IMRT treatments of the fifteen patients included in the 
study. Pinnacle3 Treatment Planning System (TPS) was used 
for the clinical practice while a beta version of Raysearch TPS 
was used retrospectively for the adaptive analysis. Quantec 
dose volume constraints were used for IMRT planning while 
for the PTV coverage V98%> 98%. The theoretical plan 
delivered to the patient, was re-calculated with Raysearch 
Station on the reference CT images. This plan was taken as 
the baseline of the treatment. The real dose delivered to the 
patient was calculated on the daily acquired CBCT and 
compared with the theoretical baseline. To track every 
treatment, the most significant cut off point for the rectum 
and for the bladder was identified for each patient, while for 
the PTV coverage V98% was considered. All the treatments 
were analyzed performing a track with the most 
representative CBCT of the weekly treatments; a total of 8/7 
CBCT were included in the recalculation. . 
Results: The PTV coverage of the delivered treatment 
recalculated on the daily CBCT not always satisfy the 
expected goal (V98%> 98%): 6 patients over 15 did not 
maintain at the end of the delivered treatment this desired 
percentage. The DVH cut off points for the bladder and the 
rectum resulting from the clinical optimization differ from 
those obtained with the real treatment delivered: one 
patient only over 15 failed for the bladder, while for the 
rectum all the patients respected the criteria at the end of 
the delivered treatment. 
Conclusions: The offline dose compensation technique in 
image guide radiation therapy can effectively consider the 
residual uncertainties which cannot be corrected online. The 
comparison of the cumulative dose with the approved 
treatment planning dose, resulted in a deviation of the 
accepted initial conditions of PTV coverage and OARs 
constraints in six over fifteen patients. For these patients a 
well-timed re-planning during the treatment would have 
avoided these discrepancies. This retrospective analysis 
suggests the need of correction strategies to improve the 
final treatment. 
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Purpose/Objective: In radiotherapy (RT) of urinary bladder 
cancer, variations in the shape, size and position of the 
bladder is a major challenge. Our institutions are therefore 
running a clinical ART daily plan selection trial for bladder 
cancer where the bladder every day is treated with the 
smallest possible PTV. Since the trial also includes patients 
who will receive elective lymph node irradiation, we are 
treating patients based on bony anatomy registration 
although set-up based on soft tissue (i.e. bladder) 
registration might be favourable. Still the increased patient 
awareness of the importance of having an empty bladder at 
each treatment session might reduce the difference between 
soft tissue vs. bony anatomy based registrations. In this study 
we are therefore comparing the difference between these 
two registration strategies for patients treated within vs. 
outside the adaptive protocol.  
Materials and Methods: This study included both the first ten 
patients from our institution included in the bladder ART trial 
(treated from December 2013) as well as the nine last 
patients treated before enrolling patients in the trial. The 
difference between bony anatomy vs soft tissue registration 
was compared between these two groups using weekly CBCTs 
for all patients. For the bony anatomy registration, the 
patients were aligned on the whole pelvic bones excluding 
the moveable part of the femoral heads. The soft tissue 
match on the bladder the registration volume was narrowed 
to approximately 1 cm from the bladder-CTV. The difference 
between the registration strategies was assessed by 
calculating the vector length of the difference from Cartesian 
coordinates. 
Results: Patients treated within the ART trial have a much 
stronger association between soft tissue and bony anatomy 
registration. Of the 10 patients treated with ART none had a 
vector length of the difference between the strategies larger 
than 2 mm. Conversely, for the 9 patients treated without 
ART only one patient had a vector length below 2 mm. The 
standard deviations of the vector length for all ART patients 
were around 1 mm while it ranged between 1 mm and 3 mm 
for the non-ART patients. The mean vector length of the 
difference was 1.5 mm for the ART patients and 3.8 mm for 
the non-ART patients the difference in the vector is 
statistical significant with a p-value of 0.0006. The vertical 
difference were statistical significant with a p-value of 
0.0044 while the longitudinal and lateral differences had a p-
value of 0.4128 respectively 0.9105 
Conclusions: For patients treated with ART the difference 
between a bony anatomy and a soft tissue registration is in 
the order of 2 mm compared to 4 mm for bladder patients 
treated before enrolment in the ART protocol. This 
difference is possibly due to the increased patient-awareness 
to the bladder emptying instruction. This awareness also 
minimize the changes of the bladder during treatment 
leading to a smaller volume irradiated. 
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Purpose/Objective: Interfractional changes in target and 
organ position and shape during external beam radiotherapy 
(EBRT) of cervical cancer patients may be of significant 
magnitude (Figure 1). To compensate for motion, application 
of relatively large CTV-PTV margins is often applied, which 
can reduce the clinical advantages of e.g. IMRT. The study 
aimed to evaluate the patterns of target and organ motion 
during EBRT and to evaluate the impact on dose delivery with 
specific focus on dose to the uterine body.  
Materials and Methods: Ten patients with locally advanced 
cervical cancer treated with chemoradiation and 
brachytherapy were analysed. EBRT was delivered as 45-50 
Gy in 25-30 fractions using daily online cone beam computed 
tomography (CBCT) for patient set up. Treatment was in 
supine position, and a drinking protocol was applied to obtain 
a full bladder. The clinical target volume (CTV) encompassed 
the gross tumour volume (GTV), cervix, parametrium, uterus, 
upper vagina and the nodal CTV. Cervix/uterus as well as 
bladder and rectum were delineated on each CBCT, and 
transferred to the planning CT. The impact of a reduced 
margin strategy of 0.5 cm CTV-PTV for the uninvolved uterus 
was compared to our standard of 1.5 cm. Uterus DVH 
parameters were extracted for each fraction and D98 was 
summed for both scenarios with evaluation of the percentage 
of fractions where D98 was less than 95% and 90% of 
prescribed dose. Bladder volume was assessed for each 
fraction to analyse for time trends and to evaluate a 
correlation between uterine coverage and bladder volume. 
Results: In 6/10 patients the uterus D98 was at least 95% of 
prescribed dose in at least 92% of all fractions for the 
reduced margin strategy. In the remaining 4 patients the D98 
was less than 95% in at least 5 fractions for the reduced 
margin strategy. In 2/4 patients the lack of coverage was 
correlated with the bladder filling which was significantly 
different from the bladder volume in the treatment planning 
scan (p=0.001, p=0.02). In 2/4 patients there was no 
correlation between bladder volume and lack of coverage 
(p=0.33, p=0.19). For all patients and for both margin 
strategies, the fractional dose summation for uterus D98 was 
>90% which corresponded to at least 40.5 Gy (table 1). 
 
Conclusions: Treatment plans with standard margin and 
reduced margin were robust to organ motion in terms of 
fractional dose summation. The uterus D98 was at least 90% 
of prescribed dose for all patients. Taking into account that 
brachytherapy delivers additional 5-10 Gy to the uninvolved 
uterine body, the summed uterine dose will be well above 
45Gy, which is often considered appropriate for targeting 
tissue at risk of microscopic spread. Dose coverage was partly 
but not consistently correlated to variation in bladder 
volume. This may indicate that an adaptive radiotherapy 
approach based on a library plan selection strategy should 
include evaluation of bladder volume and location of uterine 
body. 
